Management

Targeted Growth, Inc. is led by a team of individuals bringing depth and breadth in biotechnology, agriculture, and business.


side-images/canola_field_trials.jpg Canola field Trials

Thomas Todaro

portraits/thomas_todaro.jpg

CEO
Mr. Todaro co-founded Targeted Growth in 1999, based on novel cell cycle regulator technologies. Mr. Todaro has worked in agribusiness since 1992 directing investments in dairy processing and timber plantations. He is the former General Manager of Alamar Farms Ltd., a Canadian dairy processor located in Vancouver, B.C., and sits on the Board of Directors of BonLac Dairies in Panama City, Panama. Prior to rejoining TGI, Mr. Todaro served as Senior Vice President of Mergers & Acquisitions at PayPal. Mr. Todaro was responsible for all aspects of M&A, both national and International. He was also involved in raising over $200 Million in equity capital and the IPO of PayPal (PYPL) for $1.2 Billion in 2002. He holds a Bachelor's degree from The Colorado College and a Master's in Economics from Stanford University.

Jay De Rocher, Ph.D.

portraits/jay_derocher.jpg Scientific Director
With more than 20 years experience in plant molecular biology and biochemistry, and over 15 years of research experience with transgenic plants, Dr. De Rocher joined Targeted Growth in 2003. Previously, he worked as a Senior Scientist with EDEN Bioscience Corporation and was a postdoctoral associate at the MSU-DOE Plant Research Laboratory at Michigan State University. Dr. De Rocher received his Bachelor’s degree in Biology from the University of Washington and his Ph.D. in Molecular and Cellular Biology from the University of Arizona.

 

 

 

Margaret McCormick, Ph.D.

portraits/Margaret-pic_cropped2.jpg

Chief Operations Officer

Dr. McCormick has been with TGI since 2008, managing the company's Bio-Based Materials program as well as leading various company-wide efforts including legislative and intellectual property strategy.  Prior to joining TGI, Dr. McCormick was a partner with Integra Ventures where she led Integra's biotechnology investment strategy and its investment in TGI.  Prior to joining Integra, she was the founding president and COO of Sapphire Therapeutics (formerly Rejuvenon Corp.). Earlier in her career she was a consultant with McKinsey & Company. Dr. McCormick earned a Ph.D. in Biology (with a focus on metabolic engineering) from the Massachusetts Institute of Technology and a BS degree from the University of Wisconsin - Madison.

 

 

 

Michael Weitz

Michael-head-shot.jpg

Chief Financial Officer

Michael Weitz became Targeted Growth's Chief Financial Officer in May 2009. He has 25 years of experience in the financial management of growing companies. Prior to Targeted Growth, he held several senior financial positions at venture capital financed companies including CFO of Free & Clear, a health services provider, CFO and Vice President of Operations at Sageport, Inc., an internet  services company, and CFO and Vice President of Call Center Operations at CareWise, Inc., a health information services company. Prior to his work at CareWise, he was Vice President of Finance at Hillhaven Corporation, one of the nation's largest publicly traded senior care providers. Michael began his career with the predecessors of the CPA firms Deloitte & Touche and Ernst & Young. Michael is a CPA in the State of Washington, and a member of the American Institute of CPAs.

 

 

 

Home  :  Contact  :  Site Map © 2009 Targeted Growth, Inc.